Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene B Cone

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Plos One|November 1, 2022
Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapyEugene B Cone, Lorine Haeuser, Stephen W Reese, et al.
Minerva Urology and Nephrology|March 30, 2021
Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemicWei-Shen Tan, Maya Marchese, Marco Paciotti, et al.
JAMA Network Open|December 14, 2020
Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common CancersEugene B Cone, Maya Marchese, Marco Paciotti, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Virtual "matchmaking" without visiting electives: Overview of the early U.S. experience and potential applications to the 2021 Canadian urology matchDavid-Dan Nguyen, Chanan R Reitblat, Juan J Andino, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Plos One|November 1, 2022
Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapyEugene B Cone, Lorine Haeuser, Stephen W Reese, et al.
Minerva Urology and Nephrology|March 30, 2021
Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemicWei-Shen Tan, Maya Marchese, Marco Paciotti, et al.
JAMA Network Open|December 14, 2020
Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common CancersEugene B Cone, Maya Marchese, Marco Paciotti, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Virtual "matchmaking" without visiting electives: Overview of the early U.S. experience and potential applications to the 2021 Canadian urology matchDavid-Dan Nguyen, Chanan R Reitblat, Juan J Andino, et al.
Pageof 5